212 related articles for article (PubMed ID: 16919623)
21. The replacement of His(4) in angiotensin IV by conformationally constrained residues provides highly potent and selective analogues.
Lukaszuk A; Demaegdt H; Feytens D; Vanderheyden P; Vauquelin G; Tourwé D
J Med Chem; 2009 Sep; 52(18):5612-8. PubMed ID: 19757839
[TBL] [Abstract][Full Text] [Related]
22. Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism.
Gera L; Fortin JP; Adam A; Stewart JM; Marceau F
J Pharmacol Exp Ther; 2006 Apr; 317(1):300-8. PubMed ID: 16368899
[TBL] [Abstract][Full Text] [Related]
23. Insulin-regulated aminopeptidase: analysis of peptide substrate and inhibitor binding to the catalytic domain.
Ye S; Chai SY; Lew RA; Albiston AL
Biol Chem; 2007 Apr; 388(4):399-403. PubMed ID: 17391061
[TBL] [Abstract][Full Text] [Related]
24. [3H]IVDE77, a novel radioligand with high affinity and selectivity for the insulin-regulated aminopeptidase.
Nikolaou A; Van den Eynde I; Tourwé D; Vauquelin G; Tóth G; Mallareddy JR; Poglitsch M; Van Ginderachter JA; Vanderheyden PM
Eur J Pharmacol; 2013 Feb; 702(1-3):93-102. PubMed ID: 23376157
[TBL] [Abstract][Full Text] [Related]
25. The bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks aminopeptidase N at micromolar concentrations: off-target alterations of signaling mediated by the bradykinin B1 and angiotensin receptors.
Bawolak MT; Fortin JP; Vogel LK; Adam A; Marceau F
Eur J Pharmacol; 2006 Dec; 551(1-3):108-11. PubMed ID: 17026984
[TBL] [Abstract][Full Text] [Related]
26. Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP).
Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M; Erdélyi M; Hallberg A
J Med Chem; 2010 Nov; 53(22):8059-71. PubMed ID: 21047126
[TBL] [Abstract][Full Text] [Related]
27. Synergistic inhibition of the enzymatic activity of aminopeptidase N by divalent metal ion chelators.
Vanderheyden PM; Demaegdt H; Swales J; Lenaerts PJ; De Backer JP; Vogel LK; Vauquelin G
Fundam Clin Pharmacol; 2006 Dec; 20(6):613-9. PubMed ID: 17109655
[TBL] [Abstract][Full Text] [Related]
28. Potent macrocyclic inhibitors of insulin-regulated aminopeptidase (IRAP) by olefin ring-closing metathesis.
Andersson H; Demaegdt H; Johnsson A; Vauquelin G; Lindeberg G; Hallberg M; Erdelyi M; Karlen A; Hallberg A
J Med Chem; 2011 Jun; 54(11):3779-92. PubMed ID: 21476495
[TBL] [Abstract][Full Text] [Related]
29. From angiotensin IV binding site to AT4 receptor.
Vanderheyden PM
Mol Cell Endocrinol; 2009 Apr; 302(2):159-66. PubMed ID: 19071192
[TBL] [Abstract][Full Text] [Related]
30. Ectodomain shedding of cystinyl aminopeptidase from human placental membranes.
Ofner LD; Hooper NM
Placenta; 2002 Jan; 23(1):65-70. PubMed ID: 11869093
[TBL] [Abstract][Full Text] [Related]
31. Insulin-regulated aminopeptidase/placental leucil Aminopeptidase (IRAP/P-lAP) and angiotensin IV-forming activities are modified in serum of rats with breast cancer induced by N-methyl-nitrosourea.
Pilar Carrera M; Ramírez-Expósito MJ; Dueñas B; Dolores Mayas M; Jesús García M; De la Chica S; Cortés P; Ruíz-Sanjuan M; Martínez-Martos JM
Anticancer Res; 2006; 26(2A):1011-4. PubMed ID: 16619500
[TBL] [Abstract][Full Text] [Related]
32. Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase.
Albiston AL; McDowall SG; Matsacos D; Sim P; Clune E; Mustafa T; Lee J; Mendelsohn FA; Simpson RJ; Connolly LM; Chai SY
J Biol Chem; 2001 Dec; 276(52):48623-6. PubMed ID: 11707427
[TBL] [Abstract][Full Text] [Related]
33. The globin fragment LVV-hemorphin-7 is an endogenous ligand for the AT4 receptor in the brain.
Moeller I; Lew RA; Mendelsohn FA; Smith AI; Brennan ME; Tetaz TJ; Chai SY
J Neurochem; 1997 Jun; 68(6):2530-7. PubMed ID: 9166749
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the AT(4) receptor in a human neuroblastoma cell line (SK-N-MC).
Mustafa T; Chai SY; Mendelsohn FA; Moeller I; Albiston AL
J Neurochem; 2001 Mar; 76(6):1679-87. PubMed ID: 11259486
[TBL] [Abstract][Full Text] [Related]
35. Kinetic studies on aminopeptidase M-mediated degradation of human hemorphin LVV-H7 and its N-terminally truncated products.
John H; John S; Forssmann WG
J Pept Sci; 2008 Jul; 14(7):797-803. PubMed ID: 18236385
[TBL] [Abstract][Full Text] [Related]
36. Effects of ligands or substrate of insulin-regulated aminopeptidase (IRAP) on trophoblast invasion.
Cohen M; Wuillemin C; Chai SY; Bischof P
J Pept Sci; 2008 Jul; 14(7):883-7. PubMed ID: 18275097
[TBL] [Abstract][Full Text] [Related]
37. Ligand binding and functional properties of human angiotensin AT1 receptors in transiently and stably expressed CHO-K1 cells.
Le MT; De Backer JP; Hunyady L; Vanderheyden PM; Vauquelin G
Eur J Pharmacol; 2005 Apr; 513(1-2):35-45. PubMed ID: 15878707
[TBL] [Abstract][Full Text] [Related]
38. Identification of modulating residues defining the catalytic cleft of insulin-regulated aminopeptidase.
Ye S; Chai SY; Lew RA; Ascher DB; Morton CJ; Parker MW; Albiston AL
Biochem Cell Biol; 2008 Jun; 86(3):251-61. PubMed ID: 18523486
[TBL] [Abstract][Full Text] [Related]
39. A globin fragment, LVV-hemorphin-7, induces [3H]thymidine incorporation in a neuronal cell line via the AT4 receptor.
Moeller I; Albiston AL; Lew RA; Mendelsohn FA; Chai SY
J Neurochem; 1999 Jul; 73(1):301-8. PubMed ID: 10386983
[TBL] [Abstract][Full Text] [Related]
40. Effect of I.C.V. injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats.
Lee J; Albiston AL; Allen AM; Mendelsohn FA; Ping SE; Barrett GL; Murphy M; Morris MJ; McDowall SG; Chai SY
Neuroscience; 2004; 124(2):341-9. PubMed ID: 14980384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
